Farmacerèye SRL
Farmacerèye reported revenue of 33,000 € for the 2025 financial year (annual accounts filed with the NBB on 31 May 2026).
The score of Farmacerèye shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +78 % Total assets -8 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmacerèye's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 33,000 € | ||||
| Net result | 17,242 € | ||||
| Equity | 107,171 € | ||||
| Cash | 6,752 € | ||||
| Total assets | 326,499 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 May 2026
- Year ended 31 Dec 2024filed on 23 May 2025
- Year ended 31 Dec 2023filed on 20 May 2024
- Year ended 31 Dec 2022filed on 21 May 2023
- Year ended 31 Dec 2021filed on 05 Jun 2022
Farmacerèye's financial analysis
- Solvency32.8%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmacerèye
Farmacerèye's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0712.889.622
- VAT number
- BE0712889622
- Peppol
- Registered · 0208:0712889622 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Nov 2018
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 31 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmacerèye (SRL) has been based in Liège since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of 33,000 €, a net profit of 17,242 € and equity of 107,171 €. Its solvency stands at 32.8%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmacerèye
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Doucet-Stas Retail sale of pharmaceutical products Thimister-Clermont · balance sheet 319,537 €
- Almasart Retail sale of pharmaceutical products Le Roeulx · balance sheet 315,205 €
- Zorgapotheek Maldegem Retail sale of pharmaceutical products Maldegem · balance sheet 304,353 €
- Van de Keere Retail sale of pharmaceutical products Zottegem · balance sheet 366,717 €
- Apotheek Charlotte De Splenter Ename Retail sale of pharmaceutical products Oudenaarde · balance sheet 371,200 €
- CP Pharma Retail sale of pharmaceutical products Fléron · balance sheet 375,380 €
- Apoteek Lefever-Feyaerts Retail sale of pharmaceutical products Overijse · balance sheet 283,638 €
- SOBEN Pharma Robeerst Retail sale of pharmaceutical products Esneux · balance sheet 282,954 €
Frequently asked questions about Farmacerèye
What is the revenue of Farmacerèye?
According to the 2025 annual accounts filed with the NBB, the revenue of Farmacerèye amounts to 33,000 €.
What is the VAT number of Farmacerèye?
In Belgium, the VAT number is the company number prefixed with BE: BE0712889622 for Farmacerèye, if the company is VAT-registered. Its company number (CBE) is 0712.889.622.
Where is the registered office of Farmacerèye?
According to the CBE register, the registered office of Farmacerèye is in 4000 Liège.
What is the equity of Farmacerèye?
At the close of the 2025 financial year, the equity of Farmacerèye amounts to 107,171 €, a solvency of 32.8% of total assets.
Who manages Farmacerèye?
The register lists 3 active mandates at Farmacerèye. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmacerèye
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →